|
|
|
|
| LEADER |
00000cam a22000002a 4500 |
| 001 |
ocm46463340 |
| 003 |
OCoLC |
| 005 |
20210825113129.0 |
| 008 |
061009s2001 dcua b 00 0 eng d |
| 999 |
|
|
|c 200154
|d 200154
|
| 020 |
|
|
|a 084123745X
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d UV#
|
| 050 |
|
4 |
|a RS431.A64
|b A57
|
| 082 |
0 |
0 |
|a 616.99/4061
|2 21
|
| 245 |
0 |
0 |
|a Anticancer agents :
|b frontiers in cancer chemotherapy /
|c Iwao Ojima, Gregory D. Vite, Karl-Heinz Altmann, editor[s].
|
| 260 |
|
|
|a Washington, DC :
|b American Chemical Society,
|c c2001.
|
| 300 |
|
|
|a xii, 364 p. :
|b il. ;
|c 24 cm.
|
| 336 |
|
|
|2 rdacontent
|
| 337 |
|
|
|2 rdamedia
|
| 338 |
|
|
|2 rdacarrier
|
| 490 |
0 |
0 |
|a ACS symposium series;
|v 796
|
| 504 |
|
|
|a Incluye bibliografías.
|
| 505 |
0 |
|
|a Cancer drug discovery and development : new paradigms for a new millennium / E.A. Sausville ... [et al.] -- Evolutionary biosynthesis of anticancer drugs / George R. Pettit -- Some recent developments in the synthesis and structure-activity relationship of novel taxanes / John F. Kadow ... [et al.] -- New generation taxoids and hybrids of microtubule-stabilizing anticancer agents / Iwao Ojima ... [et al.] -- Discodermolide and taxol : a synergistic drug combination in human carcinoma cell lines / Susan Band Horwitz ... [et al.] -- Highly efficient semisynthesis of biologically active epothilone derivatives / Gregory D. Vite ... [et al.] -- Synthetic and semisynthetic analogs of epothilones : chemistry and biological activity / Karl-Heinz Altmann ... [et al.] -- Synthesis and biological activity of epothilones / Ulrich Klar ... [et al.] -- Epothilones and sarcodictyins : from combinatorial libraries to designed analogs / Nicolas Winssinger and K.C. Nicolaou -- Synthesis and structure-activity relationship studies of cryptophycins : a novel class of potent antimitotic antitumor depsipeptides / Chuan Shih ... [et al.] -- Farnesyltransferase inhibitors as potential anticancer agents / J.B. Gibbs ... [et al.] -- Farnesyltransferase inhibitors : from squalene synthase inhibitors to the clinical agent BMS-214662 / John T. Hunt -- Inhibiting farnesyl protein transferase with Sch-66336 : potentially a selective noncytotoxic therapy for human cancer / A.G. Taveras ... [et al.] -- Pyrrolo[2,3-d]pyrimidine and pyrazolo[3,4-d]pyrimidine derivatives as selective inhibitors of the EGF receptor tryosine kinase / G. Caravatti ... [et al.] -- STI571 : a new treatment modality for CML? / Jürg Zimmermann, Pascal Furet, and Elisabeth Buchdunger -- The discovery and development of second-generation matrix metalloproteinase inhibitors for the treatment of cancer / Andy Baxter and John Montana -- Prospects for antiangiogenic therapies based upon VEGF inhibition / Pascal Furet and Paul W. Manley -- Carbohydrate-based tumor antigens as antitumor vaccine agents / Jennifer R. Allen and Samuel J. Danishefsky -- Drugs to enhance the therapeutic potency of anticancer antibodies : antibody-drug conjugates as tumor-activated prodrugs / Walter A. Blättler and Ravi V.J. Chari.
|
| 650 |
|
4 |
|a Agentes antineoplásicos
|v Congresos.
|
| 700 |
1 |
|
|a Ojima, Iwao,
|d 1945-
|
| 700 |
1 |
|
|a Vite, Gregory D.
|9 370831
|
| 700 |
1 |
|
|a Altmann, Karl-Heinz.
|9 370832
|
| 710 |
2 |
|
|a American Chemical Society.
|b Division of Organic Chemistry.
|
| 710 |
2 |
|
|a American Chemical Society.
|b Division of Medicinal Chemistry.
|
| 710 |
2 |
|
|a American Chemical Society.
|b Meeting.
|n (219th :
|d 2000 :
|c San Francisco, Calif.)
|
| 901 |
|
|
|a Z0
|b UV#
|
| 902 |
|
|
|a DGBUV
|
| 942 |
|
|
|c LIBRO
|
